It has been noted that thromboembolic complications are challenging to control in EM, particularly due to the release of eosinophilic granular proteins, which could neutralize thrombomodulin's local anticoagulant activity, resulting in intracavitary thrombosis and thromboembolism [54]. Here, THBD is linked to erythema multiforme.